What Is the Most Common Blood Type and Why It Matters

Type O is the most common blood type worldwide, carried by roughly 43% of the global population, with O-positive being the single most frequent combination of ABO group and Rh factor. That dominance is not a coincidence. The reasons type O sits at the top involve evolutionary pressure, infectious disease, and a quirk of sugar chemistry on the surface of red blood cells that has practical consequences stretching from emergency rooms to pregnancy wards.

How Blood Type Frequencies Differ Across Populations

When researchers look at large blood-donor populations, type O consistently leads, but the margins shift depending on geography and ancestry. A study of blood donors found the overall frequency of group O at about 43%, followed by group A at 34%, group B at 18%, and AB at roughly 5%.¹ Within the same country, those numbers can vary dramatically by ethnic background. In the United States, type O reaches its highest proportions among Hispanic donors (about 57%), Native American donors (about 55%), and Black non-Hispanic donors (about 50%), while it drops closer to the low 40s among white non-Hispanic donors.²

The Rh factor adds another layer. About 84% of people are Rh-positive and 16% Rh-negative, though this too varies by population.¹ Rh-negative blood is far more common among people of European descent and relatively rare in East Asian and sub-Saharan African populations. That uneven distribution matters for blood banks, which need to stock products matching their local community’s mix.

Why Type O Became So Common

Evolution favors traits that help people survive long enough to reproduce, and type O appears to have earned its high frequency partly through protection against malaria. A landmark study in Mali found that children with blood group O had a 66% reduction in the odds of developing severe malaria compared with children of other blood types.³ The mechanism involves “rosetting,” a process where infected red blood cells stick to uninfected ones, forming clumps that block small blood vessels and cause organ damage. Parasites inside type O cells form smaller, less dangerous rosettes.

More recent work has refined this picture by looking at specific gene combinations rather than just the surface blood type. Red blood cells from people who carry two copies of A or B genes (AA, BB, or AB) formed significantly larger rosettes than cells from people with type OO. Interestingly, people who carry one A or B gene alongside one O gene (AO or BO) showed rosette sizes similar to type OO, suggesting that carrying even one copy of the O gene confers much of the protection.⁴ In regions where malaria has been endemic for thousands of years, this survival advantage pushed the O gene to high frequency.

Malaria is not the only infectious agent that interacts with blood type. Norovirus, the common cause of stomach bugs on cruise ships and in schools, uses sugar molecules related to blood-group antigens as its docking points on gut cells.⁵ Different norovirus strains prefer different blood-type sugars, so no single blood type wins against every strain. This kind of pathogen diversity may be one reason evolution has not wiped out A and B entirely: in different times and places, each type offers its own small advantages against specific infections.

What “Universal Donor” Actually Means

The phrase “universal donor” gets tossed around casually, but understanding what it means requires knowing what blood types are made of. The A, B, and O labels refer to sugar molecules attached to the surface of red blood cells. Type A cells carry one kind of extra sugar, type B cells carry a different one, and type O cells carry neither, leaving just a base structure called the H antigen. Your immune system makes antibodies against whichever sugar your own cells lack, which is why giving type A blood to a type B person triggers a dangerous reaction.

Type O red blood cells, lacking both the A and B sugars, do not trigger those antibodies in any recipient. That makes O-negative blood (O without the Rh protein) the safest choice when there is no time to check a patient’s type, as in a major trauma or an unconscious arrival in the emergency department.⁶ The downside is that this universal compatibility creates outsized demand. O-negative makes up only about 7% of the population in most Western countries, yet it is the first blood reached for in emergencies, leaving supplies chronically tight.

Researchers have been working on a workaround: using enzymes to snip off the extra sugars from type A and B cells, converting them into functional type O cells. The concept is straightforward in principle, since the difference between A, B, and O is just one or two sugar residues, but finding enzymes efficient and safe enough for clinical use has taken decades of work.⁶ Progress has accelerated in recent years, and if enzymatic conversion reaches the clinic, it could dramatically ease blood shortages.

Blood Type and Cardiovascular Risk

One of the most consistently replicated findings in blood-type research is that people with non-O blood types face a modestly higher risk of blood clots. The connection runs through a clotting protein called von Willebrand factor. People with types A, B, and AB tend to have higher circulating levels of this protein, which in turn raises levels of clotting factor VIII. A study tracking deep-vein thrombosis found that the risk of clots increased with rising von Willebrand factor levels and was higher in non-O individuals, with the effect at least partly working through factor VIII.⁷

The practical size of this risk increase is small for any individual person. Having type A blood does not mean you will get a blood clot; it means your baseline risk is slightly elevated compared with someone who is type O with otherwise identical health habits. For most people, the usual risk factors for clots, such as prolonged immobility, smoking, obesity, and oral contraceptive use, dwarf the contribution of blood type. But the association is real enough that some researchers have proposed factoring blood type into clot-risk assessment tools.

Blood Type and Cancer

A growing body of evidence links blood type to certain cancers, with the strongest signals for gastric and pancreatic cancer. A large genetic study combined with a meta-analysis of 40 studies found that people with blood group A had about a 19% higher risk of gastric cancer compared with type O, and those with group AB had about a 9% higher risk.⁸ The connection likely involves how blood-type antigens on the stomach lining interact with the bacterium Helicobacter pylori, which is the leading environmental cause of stomach cancer.

Pancreatic cancer shows a similar pattern. Multiple prospective studies have found that non-O blood types are associated with increased pancreatic cancer risk, and the link appears independent of H. pylori infection status.⁹ These are population-level associations. They say nothing useful about whether any individual person will get cancer. The absolute risk increase is small, and no medical guideline recommends different cancer-screening schedules based on blood type alone.

Blood Type and COVID-19

Early in the pandemic, several studies suggested that type O blood might protect against severe COVID-19, sparking widespread media coverage and public anxiety about blood type. A large retrospective study of Canadian blood donors found that type O individuals were less likely to test positive for SARS-CoV-2 and had lower odds of severe illness and death compared with non-O types.¹⁰ A study based on data from New York’s health system found higher infection prevalence among types A and B but mixed results for severity: type A actually showed lower risk of intubation and death relative to type O in some analyses.¹¹

However, as larger and more carefully controlled studies accumulated, the picture softened considerably. A multi-center study spanning three dominant variant waves found no statistically significant difference in severe outcomes among the four blood types. The proportion of composite severe disease ranged between about 8.6% and 8.9% across all groups, and multivariable analyses across different variant periods showed no significant link.¹² The early signals were likely influenced by confounding factors such as socioeconomic status, ethnicity, and access to care, which correlate with both blood type distribution and COVID outcomes. The honest summary is that blood type, if it plays any role in COVID-19 severity at all, plays a very small one.

Rh Factor and Pregnancy

The Rh system matters most during pregnancy. If a mother is Rh-negative and her baby inherits Rh-positive blood from the father, the mother’s immune system can recognize the baby’s Rh-positive cells as foreign and begin producing antibodies against them. This usually causes little trouble in a first pregnancy, but those antibodies persist. In a subsequent Rh-positive pregnancy, they can cross the placenta and attack the baby’s red blood cells, causing a condition that ranges from mild anemia to life-threatening complications.

The solution, developed in the 1960s, is an injection of anti-Rh immunoglobulin (commonly known as RhoGAM) given to the mother during and after pregnancy. A clinical trial found that none of the 48 treated mothers became actively immunized against Rh, compared with seven of 59 untreated controls.¹³ This preventive treatment has been standard care for decades and has nearly eliminated Rh disease in countries with good prenatal care. Knowing your Rh status remains one of the most practically important reasons to know your blood type.

The Rh proteins themselves are not just passive markers. They form a structural complex in the red blood cell membrane and may play a role in transporting ammonia and maintaining cell shape.¹⁴ This becomes dramatically clear in people who lack all Rh proteins entirely.

When Blood Type Is Absent Entirely

A vanishingly rare condition called Rh-null means a person’s red blood cells carry none of the Rh antigens. Fewer than 50 people worldwide have been identified with this phenotype, sometimes called “golden blood” because of its extreme rarity and theoretical universal compatibility within the Rh system. But Rh-null comes with a cost: the affected red blood cells are structurally abnormal. People with this condition typically have a mild chronic anemia characterized by oddly shaped, fragile red cells that break down faster than normal.¹⁵

Laboratory studies on Rh-null cells have found that they have about 35% to 45% more sodium-potassium pumps than normal red cells, suggesting a deeper membrane defect that the cells try to compensate for by ramping up their ion-transport machinery.¹⁶ Rh-null illustrates an important principle: blood-group proteins are not just labels for transfusion purposes. They are structural and functional components of the cell, and losing them entirely has real physiological consequences.

Beyond ABO and Rh

ABO and Rh get all the attention, but they are only two of over 40 recognized blood-group systems. After ABO and Rh, the most clinically significant are the Kell, Duffy, and Kidd systems, which together account for most of the remaining antibody-related transfusion problems.¹⁷ For someone receiving a single transfusion, these minor systems rarely cause issues. But for patients who need repeated transfusions, such as those with sickle cell disease or certain cancers, exposure to many different donors increases the chance of developing antibodies against these other blood-group antigens. Blood banks increasingly maintain databases of donor antigen profiles beyond ABO and Rh to match these patients more precisely.¹⁸

The Duffy system has its own evolutionary story that parallels the ABO-malaria connection. The Duffy-negative phenotype, extremely common in people of West African descent, prevents the malaria parasite Plasmodium vivax from entering red blood cells. In malaria-endemic zones, this trait was so heavily selected for that it reached near-fixation in some populations.¹⁸ Blood type, in the broadest sense, is a record of ancient battles between human immune systems and the pathogens that shaped them.

Blood Supply and Inventory Challenges

Knowing what blood types are common matters enormously for the logistics of keeping hospitals stocked. Blood is perishable: red blood cells last about 42 days refrigerated, and platelets only about five days. That short shelf life means blood banks walk a tightrope between having enough on hand for emergencies and not wasting units that expire before they can be used. In India, for example, roughly 10.9 million units were donated in 2016 against a requirement of 12 million, leaving a significant gap.¹⁹

O-negative blood creates a particular headache for inventory managers. Because it is given to trauma patients and anyone whose type is unknown, demand is disproportionate to the number of O-negative donors. A, B, and AB units sometimes sit longer because they can only go to recipients who match, while O-negative shelves empty first. This imbalance is one reason blood drives specifically call for O-negative donors and why some transplant programs have developed protocols for using ABO-incompatible organs rather than waiting for a perfect match.²⁰

An Evolutionary Puzzle Millions of Years Old

One of the most surprising findings in blood-type research is how ancient the system is. Genetic analysis has shown that the A and B blood types are not unique to humans. The same amino acid changes that produce A and B specificity appear in gibbons, Old World monkeys, and other primates, and the evidence supports these alleles being shared by descent rather than having evolved independently in each species. The ABO polymorphism has been maintained by balancing selection for tens of millions of years, making it the only known example of such ancient balanced polymorphism in hominoids and Old World monkeys outside of immune-system genes.²¹

Other researchers have traced the deeper evolutionary roots of the ABO gene family and found evidence of at least three independent appearances of B-type alleles from an ancestral A form across primate evolution, further supporting the idea that natural selection has repeatedly favored maintaining blood-type diversity.²² Whatever advantages each blood type provides against different pathogens or in different environments, they have been significant enough to keep all three major alleles circulating for an almost incomprehensible stretch of evolutionary time.

The Blood Type Diet and Other Myths

Given how many genuine health associations blood type has, it is not surprising that pseudoscientific claims have attached themselves to it. The most famous is the “blood type diet,” popularized in the late 1990s, which claims that people should eat different foods depending on whether they are type O, A, B, or AB. Type O individuals are told to eat like hunter-gatherers with lots of meat; type A people are told to go vegetarian; and so on. The theory sounds plausible to many people because blood type clearly matters in medicine.

But a systematic review that searched for any evidence connecting ABO blood-type diets to health outcomes found none. Of 16 studies identified, only one met the inclusion criteria, and it studied a different blood-group system entirely. No study showed any association between following an ABO-specific diet and better health.²³ People who feel better on the type O diet are probably responding to cutting processed food and eating more vegetables, changes that benefit everyone regardless of what sugars decorate their red blood cells. The blood type diet is one of those ideas that has the surface texture of science without any of the substance, and its persistence says more about the appeal of personalized health advice than about the biology of blood groups.

A related misconception, particularly popular in Japan and South Korea, holds that blood type determines personality. Type A is supposedly organized, type B is creative, type O is confident, and so on. Large studies have repeatedly found no meaningful correlation between ABO type and personality traits, yet blood-type horoscopes remain a fixture of popular culture in those countries. The temptation to read meaning into a biological label runs deep, even when the evidence runs shallow.